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THE GROWTH of subcutaneous iso-
geneic transplants of a variety of mouse
tumours has been shown to be inhibited
by both systemic (Woodruff and Boak,
1966; Woodruff and Dunbar, 1973) and
local (Likhite and Halpern, 1974; Scott,
1974; Woodruff and Dunbar, 1975) ad-
ministration of killed vaccines of certain
anaerobic corynebacteria and propioni-
bacteria. The present investigation was
undertaken to determine whether the
growth of intracerebral transplants of one
such tumour could be similarly inhibited
by systemic or local administration of an
active strain of Corynebacterium parvum,
either alone or in combination with active
specific immunotherapy, partial surgical
excision or radiotherapy.
Mice. Adult (18-22 g) female CBA/Ca
mice were used throughout.
Tumour.-The tumour (WI) was ori-
ginally induced in a female CBA/Ca
mouse with methylcholanthrene. It was
stored in liquid N2 after 15 transplant
generations, and was transplanted once
more before being used in the experiments.
Cell suspensions were prepared with pro-
nase, as previously described (Woodruff
and Boak, 1966). The final suspension in
Dulbecco's solution contained 106 viable
cells and not more than 2 x 104 non-viable
cells per ml. A suspension of 0-01 ml
(104 viable cells) was injected under ether
anaesthesia into the right cerebral hemi-
sphere through a 25-gauge needle with a
micrometer syringe. The needle, which
was inserted through the right calvarium,
was provided with a plastic stop which
limited its penetration to 4 mm.
Irradiation.-Tumour cells were irra-
diated in Petri dishes, using a Westing-
house 250 kV X-ray machine. The total
dose was 22,000 rad at a dose rate of
274 rad/min.
Mice were given 500 rad local irradia-
tion to the head with the same machine,
at a dose rate of 59-6 rad/min, using a
special container (Fig. 1) provided with
lead shielding (minimum thickness 10 mm)
which reduced the dose of irradiation to
the rest of the animal to less than 0-5 rad.
Partial excision of tumour.-A small
linear incision was made in the scalp on
the right side and the thin calvarium
exposed. A sharp-pointed scalpel was
inserted through bone and brain in a
circumferential fashion around the site of
the previous injection. A core of tissue
including bone, brain and tumour was
excised. A single suture was inserted
through the skin.
Corynebacteria.-A formalin-killed sus-
pension of C. acnes strain CN6134 (com-
monly called C.parvum) was usedthrough-
out, except in one group of mice (Group
15) in which a formalin-killed suspension
of Propionibacterium freudenreichii strain
NTC/10470 was used instead, as a control.
This organism has little or no anti-
tumour activity when given systemically
(McBride, et al., 1975).
When the material was given i.v. or
i.p. the suspension contained 0-7 mg dry
weight of organisms/ml and the dose wasM. F. A. WOODRUFF, E. HITCHCOCK AND V. L. WHITEHEAD
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FIG. Container holding 6 mice for local irradiation to the head. The floor (left) consists of paraffin
wax moulded on a perspex base, and the removable lid (right) provides heavy lead shielding to the
body and limbs of the animals.
01 ml. For intracerebral injection at the
site of tumour inoculation, the same
suspension was used when the dose was
0 07 mg: when the dose was 02 mg, the
suspension was concentrated so that the
volume injected was still 0.1 ml.
Dexamethasone.-The mice in some
groups were given repeated injections of
dexamethasone (Decadron; Merck, Sharp
& Dohme) with the object ofreducing the
incidence of cerebral oedema.
A series of experiments was set up,
each comprising one group of untreated
controls and several groups of treated
mice. There were 6 mice in each group.
As there was no significant difference in
the survival of control mice in different
experiments, the results have been pooled
and set out in a single table (Table I).
Intracerebral tumour inoculation was
well tolerated. Growing tumours gradu-
ally eroded the vault ofthe skull, and after
about 2 weeks untreated mice began to
lose weight, but showed no evidence of
pain. Three animals which had deve-
loped hind limb paralysis were killed, and
at autopsy they were found to have
extensive intracerebral tumours.
The results of treatment were as
follows:
1. Partial excision of the tumour on
Day + 9 did not prolong survival.
2. Local irradiation prolonged survival
if given on Day +3, but was ineffective if
given later (Day + 7).
3. The effect of dexamethasone was
erratic but survival was prolonged in some
mice.
Notes to Table I
a All mice received 104 viable tumour cells by intracerebral injection on Day 0.
b i.V. = intravenous injection, i.p. = intraperitoneal injection, i.t. = injection at site of tumour inocula-
tion, s.c. = subcutaneous injection.
c The results of i.v. and i.p. injection of C. parvum did not differ significantly, and have been pooled.
d C. parvum mixed with the original tumour cell inoculum.
e The large mean and s.e. in this group was due to one mouse which survived 51 days.
f C. parvum mixed with the tumour cells given therapeutically.
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4. Systemic (i.v. or i.p.) injection of
C. parvum prolonged survival if given
before tumour inoculation (Group 6) but
had little or no effect if given 3 days or
more thereafter, either alone or combined
with local irradiation.
5. A small dose (0.07 mg) of the active
strain of C. parvum (CN6134) (Group 10),
butnotoftheinactiveorganism(NTC10470),
completely prevented tumour growth if
mixed with the tumour inoculum. A
similar dose of strain CN6134 injected at
the site oftumour inoculation on Day + 1
or Day + 3 (Groups 11 and 12) prevented
tumour growth in 3/22 mice and pro-
longed survival in the remainder. The
treated mice showed temporary weight
loss of up to 4 g, but regained their pre-
treatment weight within 3-4 weeks. Addi-
tional treatment with dexamethasone
had little effect on the weight loss and,
if anything, shortened survival. Local
injection of a large dose (0-2 mg) of C.
parvum resulted in marked weight loss and
significantly shortened survival, but the
mice, which died about 7 days after
treatment, had little or no macroscopic
tumour at autopsy.
6. S.c. injection of irradiated tumour
cells, either alone or mixed with C. parvurn
CN6134 14 days prior to live challenge,
was highly effective, and prevented take
of the tumour in all except one mouse
(Groups 16 and 28). S.c. injection of
irradiated tumour cells mixed with C.
parvum on the day of live challenge
(Group 29), s.c. injection of irradiated
cells alone on Day 0 (Group 17) and of
irradiated cells mixed with C. parvum on
Day + 3 (Group 30) failed to prevent take
of the tumour (except in one mouse in
each group) but resulted in considerably
prolonged survival.
7. Injection of irradiated tumour cells
alone at the site of tumour inoculation on
Day + 3 (Group 18) was highly effective,
and prevented take in 5/6 mice. Intra-
tumour injection of irradiated cells mixed
with C. parvum on Day + 3 was moder-
ately effective in mice which also received
local irradiation (Group 33): in non-
irradiated mice (Group 31) it was less
effective than injection of C. parvum
alone. Intratumour injection of a mixture
of viable tumour cells and C. parvum
(Group 32) was highly effective without
additional local irradiation, and com-
pletely prevented tumour growth in 5/6
mice.
The comparative effectiveness of the
various immunotherapeutic procedures is
summarized in Table II.
The response of intracerebral trans-
plants of an immunogeneic tumour to
systemic or local administration of C.
parvum appears from these results to be
similar to that of subcutaneous trans-
plants, though with intracerebral trans-
plants, systemic treatment had to be
given before tumour inoculation, and the
dose which could be given locally was
limited by toxicity. It was thought that
the toxic manifestations resulted from
cerebral oedema, and it was therefore
expected that administration of dexa-
methasone would improve the situation.
This prediction was not confirmed, but
this may have been because the drug was
given only twice daily or for too short a
time. The hypothesis of cerebral oedema
cannot therefore be excluded and still
seems the most likely explanation of the
toxicity.
It has been reported that contact
inhibition of the growth of s.c. tumour
transplants by BCG (i.e. inhibition when
BCG is mixed with the tumour inoculum)
is not T-cell dependent (Moore, Lawrence
and Nisbet, 1976: Pimm and Baldwin,
1976) and probably results from local
mobilization and activation of macro-
phages, and the same is true of contact
inhibition of s.c. tumours by C. parvum
(Woodruff and Whitehead, unpublished).
It seems likely that the dramatic effect of
mixing C. parvum with tumour cells
before intracerebral inoculation was simi-
larly mediated by local mobilization and
activation of phagocytic cells. The re-
sponse of intracerebral transplants to i.v.
or i.p. injection of C. parvum may also be
due to activation of phagocytic cells, and
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TABLE II.-Comparative Effectiveness of Immunotherapeutic Procedures
Treatment
Category When given Natureb
Little or no effect Before tumour
inoculationa
Day 0 P. freudenreichii mixed with tumour inoculum
Day +3 i.v. or i.p. C. parvumc
i.v. or i.p. C. parvum + local irradiation
Moderately effective; i.e. survival Before tumour i.v. or i.p. C. parvum
prolonged but tumour grew in inoculation
most of the animals Day 0 s.c. irradiated tumour cells
Day +3 i.t. C. parvum
i.t. C. parvum mixed with irradiated tumour cells
s.c. C. parvum mixed with irradiated tumour cells
i.t. C. parvum mixed with irradiated tumour cells
+ local irradiation
Highly effective; i.e. tumour Before tumour s.c. irradiated tumour cells
failed to grow in all or nearly inoculation s.c. C. parvum mixed with irradiated tumour cells
all of the animals Day 0 C. parvum mixed with tumour inoculum
s.c. C. parvum mixed with irradiated tumour cells
Day +3 i.t. irradiated tumour cells
i.t. C. parvum mixed with viable tumour cells
a Reckoned as Day 0.
b Abbreviations (s.c., i.v., i.t., i.p.) as in Table I.
c C. parvum refers to strain CN6134.
it is just conceivable that this is true also
of the response to local injection of C.
parvum after tumour inoculation, despite
the fact that in the case of s.c. transplants
their response has been found to be highly
T-cell-dependent (Scott, 1974; Woodruff
and Dunbar, 1975; Woodruff and Warner,
1977). The dramatic response of intra-
cerebral transplants to s.c. injection of
C. parvum mixed with irradiated tumour
cells would seem to imply, however, that
such transplants are subject to inhibition
as the result of a specific immunological
reaction. This is scarcely surprising, for
it has long been known (Woodruff, 1960)
that the status ofthe brain as an immuno-
logically privileged site is by no means
absolute, and is lost in the case of trans-
plants which grow and become vascu-
larized quickly.
The results raise the question whether
it would be justifiable to set up a pilot
study oflocal and systemic administration
of C. parvum, as an addition to surgical
resection, in patients with cerebral malig-
nant gliomas. The extent to which the
clinical therapeutic response would reflect
that seen in the animal model is unpre-
dictable. The main risk, especially with
local administration of C. parvum, would
probably be cerebral oedema. Provided
the dose ofC. parvum is kept low, however,
control by standard procedures should not
prove unduly difficult in patients in whom
a bone flap is raised to provide surgical
access.
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